Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Metadata
Title
Analysis of Randomized Controlled Trials on Hepatopancreatic Surgery
Publication date
01-10-2006
Published in
Digestive Diseases and Sciences / Issue 10/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9219-9

Other articles of this Issue 10/2006

Digestive Diseases and Sciences 10/2006 Go to the issue

Original Paper

Plasma Calprotectin Levels in Patients Suffering from Acute Pancreatitis

Case Report

Aberrant Right Hepatic Sectoral Duct Injury Following Laparoscopic Cholecystectomy: Evaluation and Treatment of a Diagnostic Dilemma

Original Paper

Increased Protein Expression of Matrix Metalloproteinases -1, -3, and -9 and TIMP-1 in Patients with Gluten-Sensitive Enteropathy

Original Paper

Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium

Original Article

The Effects of Light and Moderate-Heavy Ethanol Exposure on the Development of Cirrhosis in Rats

Original Paper

Leptin in the Field of Hepatic Fibrosis: A Pivotal or an Incidental Player?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits